|VIDEO GRAND ROUNDS|
|NEUROLOGY: Genetic Testing in Epilepsy|
|Dr. Scott Perry will address epilepsy syndromes in which gene tests nay provide the etiology and alter treatment. |
Click on the following link to view the Video Grand Rounds presentation:
- Discuss the clinical features, prognosis, and evaluation of epilepsies associated with genetic mutations, specifically testing which may impact prognosis and/or treatment - SCN1A, SLC2A1, PCDH19, POLG1
- List the utility of other commonly available gene tests
- Describe the syndromes/phenotypes which may be associated with mutations in these genes, including GABRG2, KCNQ2/3, STXBP, ARX, and CDKL5.
- Discuss other genes associated with epilepsy syndromes in which impact to treatment/prognosis is variable – SCN1B, SCN2A, and SCN9A.
Genetic Testing in Epilepsy: Recognizing Syndromes in which Gene Tests May Provide the Etiology and Alter Treatment
|Audience: Physicians, Advanced Nurse Practitioners, Physician Assistants, Healthcare Professionals|
|Release Date: Tuesday, March 26, 2013|
|Retire Date: Wednesday, March 26, 2014|
|Scott Perry, MD|
Cook Children’s Neurology
|CME Enduring Material|
Cook Children's Medical Center is accredited by the Texas Medical Association to provide continuing medical education for physicians. Cook Children's designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
For any questions, please call Education at 682-885-4170.